PSEN2 and Alzheimer disease: Knowing that mutations in the APP, PSEN1, or PSEN2 genes lead to fAD, this means that APP and β- and γ-secretases are key actors in AD development and supports the hypothesis that the dysregulation of Aβ peptide production could be a cause of AD.